ইউরোপীয় ইউনিয়ন -
ডেনিশ -
EMA (European Medicines Agency)
enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunosuppressiva - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).
ইউরোপীয় ইউনিয়ন -
ডেনিশ -
EMA (European Medicines Agency)
beyfortus
astrazeneca ab - nirsevimab - immune sera og immunoglobuliner, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.